Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05713_nanopub.RAVNHDCNigRrv2HQm1eNW7SjIPsyn0OHcjkrMWE5lU8cU#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05713 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05713 label "LY-517717 [drugbank:DB05713]" assertion.
- drugbank:DB05713 seeAlso DB05713 assertion.
- drugbank:DB05713 description "LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen)." assertion.
- drugbank:DB05713 identifier "drugbank:DB05713" assertion.
- drugbank:DB05713 title "LY-517717" assertion.
- drugbank:DB05713 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05713 drugbank_vocabulary:drugbank-id "DB05713" assertion.
- drugbank:DB05713 bio2rdf_vocabulary:x-identifiers.org DB05713 assertion.
- drugbank:DB05713 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05713" assertion.
- drugbank:DB05713 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05713 bio2rdf_vocabulary:identifier "DB05713" assertion.